CF
KLRS

CNA Financial’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

CNA Financial’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-583
Closed -$265K – 203
2021
Q2 		$265K Buy
583
+74
+15% +$33.6K 0.08% 192
2021
Q1 		$274K Buy
509
+18
+4% +$9.69K 0.08% 190
2020
Q4 		$434K Buy
491
+24
+5% +$21.2K 0.14% 171
2020
Q3 		$295K Buy
+467
New +$295K 0.11% 169